…
Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Aimei Health Technology Co., Ltd Right is a Nasdaq-listed security linked to Aimei Health Technology; public filings and corporate disclosures available to international investors are limited, so the company's core products, services and markets are not clearly documented. If the issuer later substantiates proprietary healthcare technology, scalable revenue streams and access to Greater China patient or service markets, it may benefit from long-term demand for health services and digital health adoption, but those growth drivers are not verifiable today.
Material risks include low trading liquidity, heightened regulatory and delisting exposure for China-related listings, governance and financial reporting weaknesses, and significant execution uncertainty until transparent audited disclosures are provided.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| AFJKR Aimei Health Technology Co., Ltd Right |
0.05 50.00% |
0.15 | - | - | - | - |
| DOGEF Orsted A/S |
- -% |
19.75 | 28.82 | 0.66 | 6.50 | 0.07 |
| TBB AT&T Inc. 5.35% GLB NTS 66 |
0.11 0.62% |
17.75 | 4.60 | - | - | - |
| CCZ Comcast Holdings Corp |
- -% |
64.50 | 55.07 | - | - | - |
| STMZF Scottish Mortgage Investment Trust PLC |
-0.60 2.91% |
20.00 | - | - | 2.56 | - |
Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
10 East 53rd Street, New York, NY, United States, 10022
861 375 8131392
| Name | Title | Year Born |
|---|---|---|
| Mr. Juan Fernandez Pascual | CEO, Secretary & Director | 1976 |
| Mr. Heung Ming Wong | CFO & Director | 1971 |
| Mr. Junheng Xie | CEO, Secretary & Director | 1989 |
| Mr. Heung Ming Wong | CFO & Director | 1970 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.